Follicles Regen in treatment of excessive hair fall
- Conditions
- Health Condition 1: L659- Nonscarring hair loss, unspecified
- Registration Number
- CTRI/2018/10/016045
- Lead Sponsor
- Gods Own Store LLP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Participants must be adults, aged 18-65 years old with complain of excessive hair fall or damage. At screening, subjects must complete questionnaires that would provide investigators with information on their medical and hair health history and demographics. Each subjectâ??s hair length, styled layer length, average hair diameters, Hair Mass Index (HMI), Hair Breakage Index (HBI), and Healthy Hair Index (HHI) readings will be measured, calculated, and recorded.
2.Females Subjects must have a negative pregnancy test. Pregnant patients or individual with history of pregnancy will be excluded from the study.
3.Participants should be willing to sign a written consent for participation in the study and undergo a baseline interview.
4.Participants must be willing to apply the test product and return for assessment visits for evaluation.
5.Participants must agree that during the study they will refrain from taking any new herbal supplement and prescription or nonprescription medications for hair fall or dandruff treatment.
6. Participants must agree to take healthy diet and life style.
1. Single or married subjects who are pregnant or have borne children in past one year.
2. Participants with a history of shampooing hair less than three times a week as part of their current hair care regimen.
3. Participants with a history of illness or fever in past few months OR greater than 20 percent weight loss in the past 12 months OR nutritional deficiency or being on a new diet in the past six months
4. Participants with evidence or history of medical or surgical event in the past year that may significantly affect the study outcome, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders OR thyroid problems OR history of depression or severe anxiety in the past six months.
5. Participants with history of a scalp or hair loss disorder, such as alopecia, in the past 12 months
6. Patients reporting use of prescription or non-prescription drugs during the study period OR Willing to continue the use of their current hair oil.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.reduction in level of hair fall as measured by trichometer and subject self-assessment records as compared to the comparator <br/ ><br>2.Improvement in the texture, shine and hair length. <br/ ><br>3.Improvement in overall scalp health <br/ ><br>Timepoint: Baseline Day 0 <br/ ><br>Day 30 <br/ ><br>Day 60 <br/ ><br>Day 90 <br/ ><br>
- Secondary Outcome Measures
Name Time Method Safety including documentation of all adverse events, clinically significant and serious adverse events (SAEs)Timepoint: Baseline Day 0 <br/ ><br>Day 30 <br/ ><br>Day 60 <br/ ><br>Day 90